EML -22.18%: further pain for the payment card technology business after it announced issues with its remediation program on the back of Anti-money laundering concerns from the Central Bank of Ireland that was announced last year. Issues with the remediation plans have been brought to the company’s attention and works are now expected to continue into 2023 to resolve the issue. The subsidiary in question, PCSIL, has been working under growth constraints imposed by the regulator while the issues are resolved and today’s announcement adds to the risk that the limitations will be extended beyond their planned expiry in December. New CEO Emma Shand, now just 3 weeks in the role, has her work cut out for her to return the business to growth once these issues pass. There has been some corporate interest in the stock in recent months though, perhaps a get-out-of-jail-free card if needed.
scroll
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Question asked
Buy Hold Sell: The best and worst performers of FY25
Close
Friday 15th August – Dow off -11pts, SPI up +8pts
Close
Thursday 14th August – ASX +66pts, WBC, TLS, PME
Close
MM is imploring the EML board to engage with corporate interest
Add To Hit List
Related Q&A
What are your current thoughts on EML
Cutting losses in the Emerging Portfolio
Does MM believe EML is a buy?
Is MM considering EML at the moment?
Thoughts on Emeco (EHL) & Service Stream (SSM) please
Why did MM hold EML so long?
Does MM see merit in “Averaging Down”?
Does MM see trading Opportunities in ELO, EML or TYR?
MM thoughts on A2 Milk (A2M) & EML Payments (EML)
Relevant suggested news and content from the site

Video
WATCH
Buy Hold Sell: The best and worst performers of FY25
James Gerrish & Henry Jennings

Podcast
LISTEN
Friday 15th August – Dow off -11pts, SPI up +8pts
Daily Podcast Direct from the Desk

Podcast
LISTEN
Thursday 14th August – ASX +66pts, WBC, TLS, PME
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.